Gulf Drugestablished in 1969, under the visionary leadership of its founder, the Late Dr. Hassan Al Moosa. The company is one of the first to have started Pharmacies, Private Clinics, Healthcare Marketing and Distribution Services in the U.A.E. Gulf Drug proudly achieves success from its Business Entities.
Medical Equipment Business
Having three decades of extensive experience and in collaboration with the world's best medical technology providers, we have successfully accomplished in setting our name as one among the resilient and responsibleentity of the health care sector.
Fresenius Medical Care is the world's leading provider of products and services for people with chronic and Acute kidney failure. Around 3 million patients with this disease worldwide regularly undergo dialysis treatment.
We care for more than 310,000 patients in our global network of more than 3,600 dialysis clinics. At the same time, we operate 37 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables.
We aim to continuously improve the quality of life of patients with kidney disease by offering innovative products and treatment concepts of the highest quality.
HHD Home Healthcare Services a dedicated Renal Home Care Company that exclusively specializes in delivering Hemodialysis for patients suffering from End Stage Renal Disease in the comfort of their homes within the UAE.
With thousands of treatment sessions delivered and over 30 dedicated renal specialists including Nephrologists, nurses and biomedical engineers, HHD ensures ultimate patient safety is never compromised and continues to provide alternative treatment options to dialysis patients.
Vifor Pharma Group, formerly Galenica Group, is a global specialty pharmaceuticals company that researches, develops, produces and markets its own pharmaceutical products and is the partner of choice for innovative, patient-focused solutions.
The company strives to help patients around the world with severe and chronic diseases to lead better, healthier lives. The company began by building up a world-class portfolio in iron deficiency and then used this platform to expand into other areas. Today, the company has three main foci: iron deficiency with and without anaemia, nephrology and cardio-renal therapies.
Headquartered in Switzerland, Vifor Pharma Group consists of four companies: Vifor Pharma, Vifor Fresenius Medical Care Renal Pharma (VFMCRP), Relypsa and OM Pharma. Vifor Pharma Group has production sites in Switzerland and Portugal as well as a dynamic network of affiliates and partners offering broad market coverage all over the world. The company has an ever-growing global presence while at the same time remaining firmly rooted in its home market, Switzerland.
Vifor Pharma Group will deploy its expertise in its core business in iron deficiency to further pioneer key areas such as nephrology and cardio-renal. Vifor Pharma Group is an established company with the global network to serve all our stakeholders even more effectively than ever before.
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 100,000 people at Sanofi are dedicated to make a difference on patients' daily life, wherever they live and enable them to enjoy a healthier life.
Amgen is one of the world's leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.
At Amgen, we believe in a "biology first" approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases. Amgen believes the cure for disease can be found inside each one of us.
Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. In everything, we do, we aim to fulfill our mission to serve patients. In addition, every step of the way, we are guided by the values that define us.
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our businesses - Innovative Medicines, Alcon and Sandoz - are supported by functional organizations with global scale. Research and development (R&D) is at the core of our company and central to the Novartis strategy.
Baxter touches millions of lives every day. Our products and services are essential building blocks of healthcare.
You'll find Baxter's products and therapies on nearly every floor, in every department, in almost every hospital worldwide. You'll find us in clinics and in the home. Patients and providers rely on Baxter for lifesaving renal and medical products, including intravenous (IV) solutions, systems and administrative sets, IV infusion parenteral nutrition, perioperative care, pharmacy devices and software, acute renal care, and home and in-center dialysis.
Our mission to save and sustain lives inspires our work and our commitment to expanding access to care, providing cost-effective healthcare solutions, delivering quality products and advancing innovations for the world.
Our commitment to our mission means we are there when patients and healthcare professionals need us, during the critical moments that matter most.
Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition. As the leader in complement biology for over 20 years, Alexion focuses its research efforts on novel molecules and targets in the complement cascade, and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, and metabolic disorders.
When choosing a biopsy service, reliable and fast renal biopsy service is a must for patient care. ExpressMed Laboratories is CAP-accredited and our renal pathologist, Dr. Abdullah Thayyil, is an American Board Certified and has more than 15 years of experience. He was formerly a Clinical Associate Professor at the prestigious University of Iowa, Medical College Hospital in USA. We offer state-of-the-art renal biopsy consultation which is unparalleled in the region. Dr. Abdullah is particular about discussing each case with the nephrologist, which is a crucial element in the management of kidney patients. Come visit our booth at ISN-EMAN and find out more
A family-owned company founded in 1839 in Melsungen, Germany, B. Braun today is one of the world's leading healthcare companies with more than 50,000 employees working at more than 60 locations around the world. The product range includes dialysis machines and dialysis consumables for chronic and acute dialysis. In addition to its role as a manufacturer of dialysis equipment
B. Braun is an important provider of dialysis treatment. B. Braun operates 300 dialysis centers. Additional services such as holiday dialysis and pre-dialysis programs are offered in most countries, and B. Braun Avitum cooperates fully with local transplant organizations.
TauroPharm GmbH is a life science company specialized in antimicrobial medical devices. One of the company's core interests is to offer a safe and effective technology for locking central venous access devices (catheters and ports).
TauroLock™, a non-antibiotic lock solution, which is capable of dramatically reducing catheter related blood stream infections (CRBSI) is free of side-effects. The active compound is taurolidine which is not an antibiotic, but a derivative of an amino acid. TauroLock™ is highly effective in eradicating bacteria and fungi and has been successfully tested on more than five hundred organisms, including multi resistant forms such as MRSA and VRE. It is to be used in dialysis, oncology, intensive care and parenteral nutrition. To improve catheter patency TauroLock™ products contain 4% citrate and in addition heparin or urokinase.
AbbVie began as the pharmaceutical leader, Abbott, which was founded in 1888 by Chicago physician, Dr. Wallace Abbott. A new beginning; on January 1, 2013, AbbVie was founded, a global biopharmaceutical company with the focus and capabilities to address some of the world's greatest health challenges. AbbVie has the stability, resources, expertise, and passion to discover, develop, and bring to market groundbreaking science to solve the biggest health problems that face the world today and tomorrow
Biologix FZco, a company organized and existing under the laws of the United Arab Emirates, was incorporated in the Dubai Airport Free Zone in September 2002 as a regional supplier and promoter of Biotechnology products.
Biologix FZco is a service provider to Pharmaceutical and Biotech companies and performs Named Patient Supply, market access, promotion and sales, detailing, logistics, registration, medical and disease awareness activities including Pharmacovigilance and Risk Management Plan, on behalf of its partners in the Middle East and North Africa (MENA) markets.
Biologix main partners include: Acino, Amarin, Biogen, Cardiome, Celgene, Horizon Pharma, Ipsen, Jazz Pharmaceuticals, , Orexigen, Takeda and Shire.
Biologix premises are being regularly audited by the Ministry of Health in the United Arab Emirates and by its Principals and business partners. Furthermore, the company has acquired the ISO 9001:2000 Certification.
For the past 15 years, Biologix has been and continues to address the needs of patients in the MENA suffering from serious and critical conditions by ensuring a fast supply of innovative products of the highest quality.
Julphar established in 1980 is the largest generic pharmaceutical manufacturer in the MENA, producing over 200 branded products across its 15 manufacturing facilities. Julphar's mission is to offer high quality medicines at affordable prices, whilst also working towards positioning Ras Al Khaimah as a robust and growing market with a diversified economic base.
Julphar maintains a diverse product portfolio which targets major therapeutic segments: mebo & wound Care, Branded generics & General medicines.
In 2012 Julphar launched an Active Pharmaceutical Ingredient manufacturing facility, Julphar Diabetes entirely dedicated to producing raw material needed for insulin formulation. Julphar Diabetes has the capacity to produce 1500 kg of recombinant human insulin and insulin analogues crystals, equivalent to 40 million vials of insulin per year. This positions Julphar among the largest manufacturers of insulin in the world, and the only one of its kind in the Middle East.